BioSpace News Archive

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced Jessica de Paz has been selected to ride on the 2020 Donate Life Rose Parade float that will be featured in the annual Tournament of Roses® parade.

As we head into cold and flu season once again, Exergen Corporation, maker of the TemporalScanner thermometer, has created an educational video to help people understand how to tell if they have a cold or the flu.

Dong-A ST Co., Ltd. and Beactica Therapeutics AB announced that a lead compound meeting certain pre-defined criteria has been selected in their collaborative research programme aimed at developing first-in-class protein-protein interaction inhibitors for a target of therapeutic importance in cancer and other diseases.

Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, and Ambry Genetics (Ambry), a leading clinical genetic testing company, today announced that Caris will begin offering Ambry’s 67-gene CancerNext-Expanded panel to evaluate the hereditary risks for cancer.

Health & Safety Institute (HSI), a leader in Environmental Health and Safety (EHS) software, training and compliance services, today announced it has acquired leading industrial technologies training provider Martech Media, Inc.

Dr. Reddy’s Laboratories Ltd. announced the launch of Bortezomib for Injection 3.5 mg/vial, approved by the U.S. Food and Drug Administration via a 505 new drug application pathway for intravenous use only..

Ping An Healthcare and Technology Company Limited one of the world’s leading healthcare ecosystem platforms, signed a strategic collaboration agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company.

Karus Therapeutics Ltd, a clinical-stage biopharmaceutical company developing precision medicines for cancer, announces that new data will be presented from its KA2237 Phase I study at the ASH Annual Meeting & Exposition in Orlando, Florida, 9 December 2019.

Researchers studying the brain found that women taking oral contraceptives, commonly known as birth control pills, had significantly smaller hypothalamus volume, compared to women not taking the pill, according to a new study presented at the annual meeting of the Radiological Society of North America.

InterVenn Biosciences today announced that it has made its proprietary mass spectrometry analysis software available for public use.